Figure 17

![Figure 17: Spectroscopic characterization data (NMR, mass spectrometry, or HPLC) for synthesized NSAID-derived compounds. These analytical results confirm the identity and purity of each novel molecule in the Alzheimer's drug development series.]()

> Source: Ivana Cacciatore et al. "Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.." *International journal of molecular sciences*, 2016. PMID: [27376271](https://pubmed.ncbi.nlm.nih.gov/27376271/)

<figure>
  <img src="" alt="Spectroscopic characterization data (NMR, mass spectrometry, or HPLC) for synthesized NSAID-derived compounds. These analytical results confirm the identity and purity of each novel molecule in the Alzheimer's drug development series." />
  <figcaption>Figure 17. Spectroscopic characterization data (NMR, mass spectrometry, or HPLC) for synthesized NSAID-derived compounds. These analytical results confirm the identity and purity of each novel molecule in the Alzheimer's drug development series.<br>  Source: Ivana Cacciatore et al. "Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer's Disease.." <em>International journal of molecular sciences</em>, 2016. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27376271/">27376271</a></figcaption>
</figure>